TY - JOUR
T1 - Pulmonary extravascular fluid accumulation in recreational climbers
T2 - A prospective study
AU - Cremona, George
AU - Asnaghi, Roberto
AU - Baderna, Paolo
AU - Brunetto, Alessandro
AU - Brutsaert, Tom
AU - Cavallaro, Carmelo
AU - Clark, Timothy M.
AU - Cogo, Annalisa
AU - Donis, Roberto
AU - Lanfranchi, Paola
AU - Luks, Andrew
AU - Novello, Nadia
AU - Panzetta, Stefano
AU - Perini, Liliana
AU - Putnam, Marci
AU - Spagnolatti, Liliana
AU - Wagner, Harrieth
AU - Wagner, Peter D.
AU - Donner, C. F.
N1 - Funding Information:
We thank Claudio F Donner and Paolo Alciato for their support throughout the study, Sensor Medics, Cosmed, Cardioline, and MedicAir for their loan of equipment, the Club Alpino Italiano and the Alagna Cable Car Company for logistic help. We also thank the “Salvatore Maugeri” foundation, BiVer Banca, Briko, and Omnia Sport for financial assistance. UCSD investigators were supported in part by NIH HL 17731 and HL 07212.
PY - 2002/1/26
Y1 - 2002/1/26
N2 - Background: High altitude pulmonary oedema (HAPE) that is severe enough to require urgent medical care is infrequent. We hypothesised that subclinical HAPE is far more frequent than suspected during even modest climbs of average effort. Methods: We assessed 262 consecutive climbers of Monte Rosa (4559 m), before ascent and about 24 h later on the summit 1 h after arriving, by clinical examination, electrocardiography, oximetry, spirometry, carbon monoxide transfer, and closing volume. A chest radiograph was taken at altitude. Findings: Only one climber was evacuated for HAPE, but 40 (15%) of 262 climbers had chest rales or interstitial oedema on radiograph after ascent. Of 37 of these climbers, 34 (92%) showed increased closing volume. Of the 197 climbers without oedema, 146 (74%) had an increase in closing volume at altitude. With no change in vital capacity, forced expiratory volume in 1 s and forced expiratory flow at 25-75% of forced vital capacity increased slightly at altitude, without evidence of oedema. If we assume that an increased closing volume at altitude indicates increased pulmonary extravascular fluid, our data suggest that three of every four healthy, recreational climbers have mild subclinical HAPE shortly after a modest climb. Interpretation: The risk of HAPE might not be confined to a small group of genetically susceptible people, but likely exists for most climbers if the rate of ascent and degree of physical effort are great enough, especially if lung size is normal or low.
AB - Background: High altitude pulmonary oedema (HAPE) that is severe enough to require urgent medical care is infrequent. We hypothesised that subclinical HAPE is far more frequent than suspected during even modest climbs of average effort. Methods: We assessed 262 consecutive climbers of Monte Rosa (4559 m), before ascent and about 24 h later on the summit 1 h after arriving, by clinical examination, electrocardiography, oximetry, spirometry, carbon monoxide transfer, and closing volume. A chest radiograph was taken at altitude. Findings: Only one climber was evacuated for HAPE, but 40 (15%) of 262 climbers had chest rales or interstitial oedema on radiograph after ascent. Of 37 of these climbers, 34 (92%) showed increased closing volume. Of the 197 climbers without oedema, 146 (74%) had an increase in closing volume at altitude. With no change in vital capacity, forced expiratory volume in 1 s and forced expiratory flow at 25-75% of forced vital capacity increased slightly at altitude, without evidence of oedema. If we assume that an increased closing volume at altitude indicates increased pulmonary extravascular fluid, our data suggest that three of every four healthy, recreational climbers have mild subclinical HAPE shortly after a modest climb. Interpretation: The risk of HAPE might not be confined to a small group of genetically susceptible people, but likely exists for most climbers if the rate of ascent and degree of physical effort are great enough, especially if lung size is normal or low.
UR - http://www.scopus.com/inward/record.url?scp=0037176533&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037176533&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(02)07496-2
DO - 10.1016/S0140-6736(02)07496-2
M3 - Article
C2 - 11830197
AN - SCOPUS:0037176533
SN - 0140-6736
VL - 359
SP - 303
EP - 309
JO - Lancet
JF - Lancet
IS - 9303
ER -